| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys
|
Kärnell, Anders
|
|
1993
|
11 |
8 |
p. 830-836
7 p.
|
article
|
| 2 |
Borrelia burgdorferi gene encoding conserved 79 kDa antigen: DNA probe or DNA primer and polymerase chain reaction for Lyme disease diagnosis and recombinant vaccine; monoclonal antibody production
|
|
|
1993
|
11 |
8 |
p. 879-
1 p.
|
article
|
| 3 |
Calendar
|
|
|
1993
|
11 |
8 |
p. 880-
1 p.
|
article
|
| 4 |
Envelope region nucleic acid fragment of type-C hepatitis virus and its detection; diagnosis using hepatitic C virus DNA probe or RNA probe; DNA sequence; potential recombinant vaccine preparation
|
|
|
1993
|
11 |
8 |
p. 879-
1 p.
|
article
|
| 5 |
Evidence for the role of human immunodeficiency virus type 1 Nef protein as a growth inhibitor to CD4+ T lymphocytes and for the blocking of the Nef function by anti-Nef antibodies
|
Fujii, Yoichi
|
|
1993
|
11 |
8 |
p. 837-847
11 p.
|
article
|
| 6 |
Global immunization against AIDS: economic considerations
|
Petricciani, John C.
|
|
1993
|
11 |
8 |
p. 873-877
5 p.
|
article
|
| 7 |
Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines
|
Miyazaki, Chiaki
|
|
1993
|
11 |
8 |
p. 853-858
6 p.
|
article
|
| 8 |
Induction of immunological response to mammal pathogen; rabies virus, cattle leukaemia virus, cat leukaemia virus or herpes simplex virus antigen gene cloning in an avipox virus vector for use as a recombinant vaccine
|
|
|
1993
|
11 |
8 |
p. 878-
1 p.
|
article
|
| 9 |
New nucleic acid encoding E2 protein of canine corona virus; dog corona virus recombinant E2 protein production; may be used in recombinant vaccine production
|
|
|
1993
|
11 |
8 |
p. 878-
1 p.
|
article
|
| 10 |
Of postulates and peccadilloes: Robert Koch and vaccine (tuberculin) therapy for tuberculosis
|
Burke, Donald S.
|
|
1993
|
11 |
8 |
p. 795-804
10 p.
|
article
|
| 11 |
Peptide blocking the binding of P. aeruginosa to buccal epithelial cells; Pseudomonas aeruginosa recombinant epitope peptide production for use as recombinant vaccine and as adjuvant in lung cancer therapy
|
|
|
1993
|
11 |
8 |
p. 879-
1 p.
|
article
|
| 12 |
Peptides corresponding to regions of HPV-16 E1 and E2 proteins: human recombinant papilloma virus-16 E1 and E2 protein sero-reactive region and monoclonal antibody useful in cervix carcinoma vaccine, diagnosis
|
|
|
1993
|
11 |
8 |
p. 878-
1 p.
|
article
|
| 13 |
Prevention of transmission of simian immunodeficiency virus from vaccinated macaques that developed transient virus infection following challenge
|
Shafferman, Avigdor
|
|
1993
|
11 |
8 |
p. 848-852
5 p.
|
article
|
| 14 |
Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles
|
von Brunn, Albrecht
|
|
1993
|
11 |
8 |
p. 817-824
8 p.
|
article
|
| 15 |
Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA
|
Roberts, Mark
|
|
1993
|
11 |
8 |
p. 866-872
7 p.
|
article
|
| 16 |
Protection of swine against foot-and-mouth disease with viral capsid proteins expressed in heterologous systems
|
Grubman, Marvin J.
|
|
1993
|
11 |
8 |
p. 825-829
5 p.
|
article
|
| 17 |
Retrovirus-mediated recombinant fusion protein preparation; vector with Rous-sarcoma virus gag gene myristylation site for recombinant vaccine production in CV-1, COS-1, NIH3T3 or turkey embryo fibroblast cell culture as membranous particle
|
|
|
1993
|
11 |
8 |
p. 878-
1 p.
|
article
|
| 18 |
Role of central nervous system and behaviour in the immune response
|
Husband, Alan J.
|
|
1993
|
11 |
8 |
p. 805-816
12 p.
|
article
|
| 19 |
Systematic identification of T-cell activating epitopes on the human immunodeficiency virus type 1 envelope glycoprotein gp120 in primates immunized with synthetic peptides
|
Eriksson, Kristina
|
|
1993
|
11 |
8 |
p. 859-865
7 p.
|
article
|
| 20 |
Vaccine containing cattle papilloma virus-2 and/or cattle papilloma virus-4 L2 protein; for use as recombinant vaccine or in tumour therapy
|
|
|
1993
|
11 |
8 |
p. 878-879
2 p.
|
article
|
Journal description